Prophylaxis against hepatitis B recurrence following liver transplantation in HBs Ag(+) patients.
Lee
S K
SK
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Park
J H
JH
Joh
J W
JW
Kim
S J
SJ
Choi
I S
IS
Choi
S H
SH
Heo
J S
JS
Lee
W Y
WY
Sohn
T S
TS
Kim
Y I
YI
Paik
S W
SW
Koh
K C
KC
Lee
J H
JH
Kim
S M
SM
Peck
K R
KR
Song
J H
JH
Lee
B B
BB
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D002102:Cadaver; D004359:Drug Therapy, Combination; D005260:Female; D006509:Hepatitis B / Q000517:prevention & control* / Q000601:surgery*; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000379:methods / Q000401:mortality; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012189:Retrospective Studies; D015996:Survival Rate; D014019:Tissue Donors
D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens; D007136:Immunoglobulins; D007166:Immunosuppressive Agents; D019259:Lamivudine; C045213:hepatitis B hyperimmune globulin